Related Experiment Video
Updated: Aug 4, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Complicated Invasive Pneumococcal Meningitis: Highlighting the Value of Implementing New Pneumococcal Vaccines
1Pediatrics, Medical University of South Carolina, Charleston, USA.
Insights
Invasive pneumococcal disease (IPD) caused by non-vaccine serotypes is a growing concern. This case highlights a severe IPD infection in a vaccinated child, emphasizing the need for new vaccines.
Area of Science:
- Microbiology
- Immunology
- Pediatrics
Background:
- Invasive pneumococcal disease (IPD) is a significant global health threat, particularly in children.
- Current pneumococcal vaccines have decreased IPD incidence but not eliminated it.
- Emerging non-vaccine serotypes pose a challenge to existing vaccination strategies.
Observation:
- A previously healthy, vaccinated 23-month-old male presented with severe illness.
- The patient developed septic shock, meningitis, and stroke.
- The causative agent was identified as an invasive non-vaccine serotype of Streptococcus pneumoniae.
Findings:
- This case demonstrates a severe, life-threatening invasive pneumococcal disease caused by a non-vaccine serotype.
- The patient's vaccination status did not prevent this severe outcome.
- The specific non-vaccine serotype responsible for the severe IPD was identified.
Implications:
- This case underscores the urgent need for novel pneumococcal vaccines targeting emerging non-vaccine serotypes.
- It highlights the potential for severe IPD even in vaccinated individuals.
- Further research into serotype distribution and vaccine efficacy against non-vaccine strains is critical.
Abstract:
Invasive Streptococcus pneumoniae disease (IPD) remains a serious cause of morbidity and loss of life in children and adults worldwide. While pneumococcal vaccines have reduced the frequency of invasive pneumococcal disease, the emergence of invasive non-vaccine serotypes has mandated the development of novel pneumococcal vaccines to further protect against these emerging serotypes. We present a case of a non-vaccine serotype invasive pneumococcal disease-causing septic shock, meningitis, and stroke in a previously healthy and appropriately vaccinated 23-month-old male.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia II: Pathophysiology

